Optical coherence tomography quantitative analysis of iris volume changes after pharmacologic mydriasis.
about
Angle-closure glaucoma: diagnosisGenome-wide association analyses identify three new susceptibility loci for primary angle closure glaucomaAnterior segment imaging in glaucoma: An updated review.An inverse method to determine the mechanical properties of the iris in vivoPupil dynamics in Chinese subjects with angle closure.Anatomic predictors for anterior chamber angle opening after laser peripheral iridotomy in narrow angle eyes.Peripheral laser iridoplasty opens angle in plateau iris by thinning the cross-sectional tissues.Understanding the causation of primary angle closure disease using the sufficient component cause model.Non-steroidal drug-induced glaucoma.Comparison of Physiologic versus Pharmacologic Mydriasis on Anterior Chamber Angle Measurements Using Spectral Domain Optical Coherence TomographyVariants in Nebulin (NEB) Are Linked to the Development of Familial Primary Angle Closure Glaucoma in Basset Hounds.Optimal number of angle images for calculating anterior angle volume and iris volume measurements.Differences in baseline dark and the dark-to-light changes in anterior chamber angle parameters in whites and ethnic Chinese.Establishing Age-Adjusted Reference Ranges for Iris-Related Parameters in Open Angle Eyes with Anterior Segment Optical Coherence Tomography.Factors influencing the pupillary light reflex in healthy individuals.Comparison of dynamic changes in anterior ocular structures examined with anterior segment optical coherence tomography in a cohort of various origins.Gonioscopic features in patients with acute and chronic angle-closure glaucoma.Contribution of different anatomical and physiologic factors to iris contour and anterior chamber angle changes during pupil dilation: theoretical analysis.Clinical and Anterior Segment Anatomical Features in Primary Angle Closure Subgroups Based on Configurations of Iris Root Insertion.Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters.Anterior chamber angle imaging with optical coherence tomography.Determinants of pupil diameters and pupil dynamics in an adult Chinese population.An Evaluation of Effects of Different Mydriatics on Choroidal Thickness by Examining Anterior Chamber Parameters: The Scheimpflug Imaging and Enhanced Depth Imaging-OCT Study.Anterior segment changes after pharmacologic mydriasis using Pentacam and optical coherence tomography in angle closure suspects.Dark-light change of iris parameters and related factors among American Caucasians, American Chinese, and Mainland Chinese.Associated factors of acute primary angle closure glaucoma in a sub-group of Chinese people: comparison between attack eyes and normal controls.Predictors of Intraocular Pressure After Phacoemulsification in Primary Open-Angle Glaucoma Eyes with Wide Versus Narrower Angles (An American Ophthalmological Society Thesis).Diurnal Variation of Optical Coherence Tomography Measurements of Static and Dynamic Anterior Segment Parameters.Automated Detection of Iris Furrows and their Influence on Dynamic Iris Volume Change.Primary angle closure glaucoma (PACG) susceptibility gene PLEKHA7 encodes a novel Rac1/Cdc42 GAP that modulates cell migration and blood-aqueous barrier function.Anterior segment imaging-based subdivision of subjects with primary angle-closure glaucoma.Effect of mydriasis induced by topical instillations of 0.5% tropicamide on the anterior segment in normotensive dogs using ultrasound biomicroscopy.Role of anterior segment optical coherence tomography in angle-closure disease: a review.Numerical stress analysis of the iris tissue induced by pupil expansion: Comparison of commercial devices.Ocular Biometric Characteristics of Chinese with History of Acute Angle Closure
P2860
Q26828853-082D75DD-EE31-4428-9174-FE67E4BF2943Q28943447-1CC843DB-418E-4A58-BA7B-E212FAE7264FQ30394505-8D786B97-EB3A-4561-9FA8-02D6E2C50A28Q30436219-2AFD2A25-2DBC-4758-88E5-76CE2A70B8E8Q34145161-77C5228F-53A6-43A7-8373-96FAD9D124DCQ34262248-9CBCA888-BE4E-418C-94FD-0414EE6574D6Q35012895-04E12507-35B1-4357-9809-AB8FDFA6D9CBQ35015662-093596C9-14F3-4CB5-8301-FACC18FF074DQ35226937-15F9FEFE-6C61-453E-9038-810F6B28A785Q35279038-217FC7DD-1071-4F88-9704-98C1D5DB3221Q35566283-FD565E79-BE00-46A0-B291-709E5DCEDAE6Q35569723-B4D5AFA6-90B6-40EE-AD1E-AE72CB5D5CA4Q35801485-0F2332C7-1F70-4F64-A6AF-F589E05701BEQ35905691-E2D41529-1EC0-4D95-BB7B-62002E7875E5Q35954469-D95EBC6E-52C4-4E45-8B70-B4DFA2422AEAQ36103366-D66E60EA-B88A-4976-821E-8290351092F1Q36574182-1D3EB1EA-6CE9-4A20-B419-0A48C4CC826FQ36802001-76B94AA6-7C0D-4986-AB8D-C36F853363E9Q36932319-FA41D45E-A8B6-4E2D-AE62-DC693FEF7236Q37418051-97FFD2A5-73DF-4731-B9E7-825437D93D5CQ38543706-6A56D6F8-816A-4D90-A6E0-E8FB7F476D0BQ40951017-D62874C3-764E-4AE5-9EBD-0CD41370C604Q42593367-E6AFD867-1A1E-4860-A602-0BA44ACBFDFBQ43191073-E0AC84F0-6131-4E9A-9050-54ECF580DFFDQ44837428-B49E581B-58D4-4113-A11A-E301E937E8E9Q44983823-4D936725-077A-4006-ABD7-C67F3D589A1CQ45374883-951838BB-E138-4272-ABA4-BEE601819FD7Q46284614-4091B93E-A41C-4680-93A6-CFE17F3C963CQ47095139-2ACEC238-6928-49F6-89B5-83FB17B22483Q47670930-449A3658-13CF-48DD-B1D8-47D3504B5B10Q47921671-A28036DD-A27E-4341-8410-D5371BD10BB1Q48217097-EDDF7AC8-9547-4B4C-A2C7-FC8508684440Q49377694-8FA69792-4D4F-4EC9-9436-04BEEA473102Q52655972-DBBE5F97-84A7-4AFA-9F90-018D77F1C471Q58699541-140A0110-506C-4851-96C2-22CDE07E6E1E
P2860
Optical coherence tomography quantitative analysis of iris volume changes after pharmacologic mydriasis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Optical coherence tomography q ...... after pharmacologic mydriasis.
@ast
Optical coherence tomography q ...... after pharmacologic mydriasis.
@en
type
label
Optical coherence tomography q ...... after pharmacologic mydriasis.
@ast
Optical coherence tomography q ...... after pharmacologic mydriasis.
@en
prefLabel
Optical coherence tomography q ...... after pharmacologic mydriasis.
@ast
Optical coherence tomography q ...... after pharmacologic mydriasis.
@en
P1433
P1476
Optical coherence tomography q ...... after pharmacologic mydriasis
@en
P2093
Philippe Denis
P356
10.1016/J.OPHTHA.2009.10.030
P577
2009-11-17T00:00:00Z